Mary A. McLean
Mary A. McLean
University of Cambridge
Geverifieerd e-mailadres voor cancer.org.uk
Geciteerd door
Geciteerd door
Metabolic profiles of human brain tumors using quantitative in vivo 1H magnetic resonance spectroscopy
FA Howe, SJ Barton, SA Cudlip, M Stubbs, DE Saunders, M Murphy, ...
Magnetic Resonance in Medicine: An Official Journal of the International …, 2003
Brain metabolite changes in cortical grey and normal‐appearing white matter in clinically early relapsing–remitting multiple sclerosis
DT Chard, CM Griffin, MA McLean, P Kapeller, R Kapoor, AJ Thompson, ...
Brain 125 (10), 2342-2352, 2002
Glutamate dysfunction in people with prodromal symptoms of psychosis: relationship to gray matter volume
JM Stone, F Day, H Tsagaraki, I Valli, MA McLean, DJ Lythgoe, ...
Biological psychiatry 66 (6), 533-539, 2009
Elevated white matter myo‐inositol in clinically isolated syndromes suggestive of multiple sclerosis
KTM Fernando, MA McLean, DT Chard, DG MacManus, CM Dalton, ...
Brain 127 (6), 1361-1369, 2004
Spinal cord spectroscopy and diffusion-based tractography to assess acute disability in multiple sclerosis
O Ciccarelli, CA Wheeler-Kingshott, MA McLean, M Cercignani, ...
Brain 130 (8), 2220-2231, 2007
Quantitative analysis of short echo time 1H‐MRSI of cerebral gray and white matter
MA McLean, FG Woermann, GJ Barker, JS Duncan
Magnetic Resonance in Medicine: An Official Journal of the International …, 2000
Continuing ischemic damage after acute middle cerebral artery infarction in humans demonstrated by short-echo proton spectroscopy
DE Saunders, FA Howe, A van den Boogaart, MA McLean, JR Griffiths, ...
Stroke 26 (6), 1007-1013, 1995
Short echo time single‐voxel 1H magnetic resonance spectroscopy in magnetic resonance imaging–negative temporal lobe epilepsy: Different biochemical profile …
FG Woermann, MA McLean, PA Bartlett, GJ Parker, GJ Barker, JS Duncan
Annals of Neurology: Official Journal of the American Neurological …, 1999
Preliminary evidence for neuronal damage in cortical grey matter and normal appearing white matter in short duration relapsing-remitting multiple sclerosis: a quantitative MR …
P Kapeller, MA McLean, CM Griffin, D Chard, GJM Parker, GJ Barker, ...
Journal of neurology 248, 131-138, 2001
Altered relationship between hippocampal glutamate levels and striatal dopamine function in subjects at ultra high risk of psychosis
JM Stone, OD Howes, A Egerton, J Kambeitz, P Allen, DJ Lythgoe, ...
Biological psychiatry 68 (7), 599-602, 2010
Proton MRS reveals frontal lobe metabolite abnormalities in idiopathic generalized epilepsy
RJ Simister, MA McLean, GJ Barker, JS Duncan
Neurology 61 (7), 897-902, 2003
Quantifying normal human brain metabolism using hyperpolarized [1–13C] pyruvate and magnetic resonance imaging
JT Grist, MA McLean, F Riemer, RF Schulte, SS Deen, F Zaccagna, ...
Neuroimage 189, 171-179, 2019
Thalamic glutamate levels as a predictor of cortical response during executive functioning in subjects at high risk for psychosis
P Fusar-Poli, JM Stone, MR Broome, I Valli, A Mechelli, MA McLean, ...
Archives of general psychiatry 68 (9), 881-890, 2011
Metabolite changes in normal-appearing gray and white matter are linked with disability in early primary progressive multiple sclerosis
J Sastre-Garriga, GT Ingle, DT Chard, L Ramió-Torrentą, MA McLean, ...
Archives of neurology 62 (4), 569-573, 2005
Imaging breast cancer using hyperpolarized carbon-13 MRI
FA Gallagher, R Woitek, MA McLean, AB Gill, R Manzano Garcia, ...
Proceedings of the National Academy of Sciences 117 (4), 2092-2098, 2020
Advanced ovarian cancer: multiparametric MR imaging demonstrates response-and metastasis-specific effects
E Sala, MY Kataoka, AN Priest, AB Gill, MA McLean, I Joubert, MJ Graves, ...
Radiology 263 (1), 149-159, 2012
Metabolite changes in early relapsing–remitting multiple sclerosis: A two year follow–up study
M Tiberio, DT Chard, DR Altmann, G Davies, CM Griffin, MA McLean, ...
Journal of neurology 253, 224-230, 2006
Stents for blood vessels
DJ Doorly, CG Caro, MA McLean
US Patent 6,554,856, 2003
A comparison of quantitative methods for clinical imaging with hyperpolarized 13C‐pyruvate
CJ Daniels, MA McLean, RF Schulte, FJ Robb, AB Gill, N McGlashan, ...
NMR in Biomedicine 29 (4), 387-399, 2016
Relationship between brain glutamate levels and clinical outcome in individuals at ultra high risk of psychosis
A Egerton, JM Stone, CA Chaddock, GJ Barker, I Bonoldi, RM Howard, ...
Neuropsychopharmacology 39 (12), 2891-2899, 2014
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20